← All ECL analyses

Ecolab Inc.

ECL · Materials
B ★★★ Hold
Jul 10, 2026 · Score 84 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $273.03
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $260.00 ($250.00–$270.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $321.30
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+17.7%

Type A - Ecolab Inc. (ECL) 20260710 Stock Analysis

📅 Ecolab Key Upcoming Events

🏢 Step 1: Ecolab Company Overview & Business Model

Q1-A1. What is Ecolab?

Q1-A2. How Does Ecolab Make Money?

Q1-A3. Ecolab’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Ecolab’s Competitors?

Q1-A5. Ecolab Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Ecolab’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Ecolab Have a Durable Economic Moat?

Q2-A2. Is Ecolab’s Growth Sustainable?

Q2-A3. How Does Ecolab Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Ecolab Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Ecolab? (Margins & ROIC)

Q3-A3. What Drives Ecolab’s Returns? (ROIC Breakdown)

Q3-A4. Are Ecolab’s Earnings High Quality?

Q3-A5. Is Ecolab’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Ecolab Forensic Accounting & Dilution Review

Q4-A1. Does Ecolab Have Accounting Red Flags?

Q4-A2. Is Ecolab Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Ecolab’s Cash Flow?

Q4-A4. Is Ecolab Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Ecolab Management & Shareholder Alignment

Q5-A1. Can You Trust Ecolab’s Management? (Guidance Track Record)

Q5-A2. What Are Ecolab Insiders Doing?

Q5-A3. Is Ecolab’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Ecolab Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Ecolab Guidance

Q6-A2. What Is Ecolab’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Ecolab Catalysts & Price Triggers

Q7-A1. What Could Move Ecolab Stock? (Top 3 Catalysts)

Q7-A2. Ecolab’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Ecolab Fairly Valued? Valuation Analysis

Q8-A1. Ecolab’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Ecolab vs Peers: Valuation Comparison

Q8-A3. Is Ecolab Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Ecolab? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. Ecolab’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Ecolab? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Ecolab?

Q9-A2. How Sensitive Is Ecolab to the Economy?

Q9-A3. Ecolab Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Ecolab Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Ecolab? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Ecolab’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Ecolab’s Exposure to Stagnant Heavy Industries Its Biggest Weakness?

Q2: Can Ecolab’s 32x Forward P/E Be Justified by the AI Liquid Cooling Boom?

Q3: Will the “One Ecolab” Initiative Deliver the Promised Margin Expansion?

Q4: How Bulletproof Is Ecolab’s Pricing Power Against Raw Material Inflation?

Q5: Is the $9.27 Billion Debt Load a Threat in a “Higher for Longer” Rate Environment?

Q6: Can the Global Life Sciences Segment Maintain Its Hyper-Growth?

Q7: Will Institutional & Specialty Volumes Recover Fully From Pandemic Hangovers?

Q8: Does the Dividend Yield Provide Sufficient Downside Protection?

Q9: Can Competitors Replicate the 3D TRASAR™ Digital Moat?

Q10: Is the Board’s Capital Allocation Strategy Too Aggressive?

Ecolab Inc. (ECL)